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Abstract
To characterize respiratory virus infections during the first autumn–winter season of pandemic A (H1N1) 2009 influenza virus (A/H1N1/
2009) circulation, a prospective study in children attending a paediatric emergency department at the Sapienza University hospital, Rome,
was conducted from November 2009 to March 2010. By means of both nasal washings and pharyngeal swabs, enrolled children were
checked for 14 respiratory viruses. The majority of acute respiratory infections resulted from viral pathogens (135/231, 58%). Overall, the
most common was respiratory syncytial virus (RSV), in 64% of positive samples; A/H1N1/2009 was the only influenza virus found in 16%
and rhinovirus (RV) in 15%. Virus-positive children did not differ significantly from virus-negative children in signs and symptoms at presen-
tation; of the virus groups, RSV-infected children were younger and more frequently admitted to intensive-care units than those infected
with A/H1N1/2009 and RV. Of the hospitalized children, stratified by age, both infants and children aged >1 year with RSV were most
severely affected, whereas A/H1N1/2009 infections were the mildest overall, although with related pulmonary involvement in older chil-
dren. Children with RV infections, detected in two flares partially overlapping with the A/H1N1/2009 and RSV peaks, presented with
bronchiolitis, wheezing and pneumonia. Leukocytosis occurred more frequently in RV-infected and A/H1N1/2009-infected children, and
numbers of blood eosinophils were significantly elevated in RV-infected infants. Given the fact that clinical and epidemiological criteria are
not sufficient to identify viral respiratory infections, a timely virological diagnosis could allow different infections to be managed separately.
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Introduction
Hospital emergency departments (EDs) experience pressure
on admissions during the winter months, because of respira-
tory infections; in winter, various respiratory pathogens that
present with similar symptoms circulate widely in children
[1]. Diagnosis of influenza virus infections, as with other
respiratory pathogens, is usually based on clinical and epide-
miological criteria, and is only rarely confirmed virologically
[2]. However, lack of an aetiological diagnosis could hamper
efforts to reduce the risk of pathogen transmission and the
efficient use of the proper antiviral drugs. In order to evalu-
ate the relative impact of a novel virus, laboratory-confirmed
data are needed on hospitalization rates for and clinical
courses of respiratory viral infections.
In Italy, as in other northern hemisphere countries, pan-
demic A (H1N1) 2009 influenza virus (A/H1N1/2009) caused a
first peak of infection in the spring and early summer months of
2009, and there was a second flare during the autumn, the nor-
mal epidemic period for various respiratory viruses. Recent
papers have focused on the clinical course of A/H1N1/2009 infec-
tion [3–5], comparing patient data from the paediatric population
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE VIROLOGY
with those available for seasonal influenza infections, but not with
other respiratory virus clinical presentations and courses. In only
one prospective study [3], conducted in the southern hemi-
sphere, were the clinical features of A/H1N1/2009 compared
with those of several other respiratory viruses (although not rhi-
novirus (RV) and other recently identified viruses).
The fact that A/H1N1/2009 circulates concurrently with
other respiratory agents points to a need for better data on
the epidemiology, clinical presentation and course of infec-
tions caused by the different respiratory viruses.
Accordingly, with the aim of characterizing respiratory
viral infections during the first autumn–winter season charac-
terized by A/H1N1/2009 circulation, children attending a
paediatric ED in Rome for acute respiratory infections,
whether subsequently hospitalized or not, were prospec-
tively enrolled between November 2009 and March 2010.
The signs and symptoms, laboratory data and clinical out-
comes were then compared in order to characterize
A/H1N1/2009 from other respiratory virus infections.
Materials and Methods
Patients
Between November 2009 and March 2010, consecutive chil-
dren (age 0–16 years) attending the paediatric ED of a teaching
hospital (Policlinico Umberto I, ‘Sapienza’ University of Rome,
one of the largest EDs in Rome, with approximately 30 000
consultations per year) were eligible for enrolment in the
study, if they presented with fever at admission (tempera-
ture ‡38C) or in the preceding days and/or with at least one
acute respiratory symptom (rhinorrhoea, cough, wheezing, or
respiratory distress). Exclusion criteria were underlying chronic
diseases (including cystic fibrosis, chronic pulmonary disease,
congenital heart disease, and immunodeficiency). Informed con-
sent was sought from the children’s parents for them to partici-
pate in the study, which had been approved by the hospital’s
Ethics Committee. To ensure accurate virological diagnosis,
two respiratory specimens—a pharyngeal swab (PS) (Virocult;
Medical Wire and Equipment, Corsham, UK) and a nasal wash-
ing (NW) (3 mL of sterile saline solution injected into each
nostril and collected with a syringe)—were taken during ED
consultation from enrolled children, whether subsequently hos-
pitalized or not. Detailed demographic, clinical and laboratory
data were obtained from the patients’ medical files. A severity
score ranging from 0 to 8 was assigned according to respira-
tory rate (age-adjusted), arterial oxygen saturation in room air
(0, >95%; 1, 95–90%; 2, <90%), the presence of retractions (0,
none; 1, present;; 2, present + nasal flare), and ability to feed
(0, normal; 1, reduced; 2, intravenous) [6].
PCR-based test for respiratory virus detection
Within 24 h of arrival at the virology laboratory, aliquots of
the PS medium (140 lL) that had been collected were used
for RNA extraction with a QIAamp Viral RNA Mini Kit
(Qiagen, Santa Clara, CA, USA), and subjected to reverse
transcription driven by random hexamers, with the High-
Capacity cDNA Archive Kit (Applied Biosystems, Monza,
Italy). NW samples were vortexed to shear mucus, and
divided into three aliquots, one of which was used for RNA
extraction as described above. Detection of the influenza A
virus was performed with a PCR assay targeting the influenza
M gene, according to WHO protocols (http://www.who.int/
csr/resources/publications/swineflu/diagnostic_recommenda-
tions/en/index.html). Positive samples were subjected to a
further PCR reaction, in nested format, targeting the M
genomic sequence specific for A/H1N1/2009, with primer
pairs designed for this study (first round—MEXF5, 5¢-
TGCATGGGCCTCATATATACAA-3¢, and MEXR5, 5¢-AT
GACCATCGTCAACATCCA-3¢; second round—SM670,
5¢-AGCTCCAGTGCTGGTCTGAAAG-3¢, and SMR900, 5¢-
GACTCAGGCACTCCTTCCGTAGAA-3¢), and confirmed
by sequencing. Thirteen respiratory viruses other than influ-
enza A virus (influenza B virus, respiratory syncytial virus
(RSV), adenovirus, RV, parainfluenza viruses (PIVs)1–3,
human metapneumovirus (hMPV), coronaviruses OC43,
229E, NL63 and HKU1, and human bocavirus (hBoV)) were
tested for with PCR assays, as previously described [7,8]. A
case was defined as positive when at least one of each type
of sample (NW and PS) gave a positive result.
Quantitative real-time PCR technique for A/H1N1/2009
Viral genome quantification was performed on cDNA from
the most A/H1N1/2009-positive PS sample. Primers and
probes targeting the influenza M gene were derived from
CDC protocols (http://www.who.int/csr/resources/publica-
tions/swineflu/CDCrealtimeRTPCRprotocol_20090428) and
adapted for use in a 5¢-exonuclease TaqMan-based real-time
PCR technique. The standards were obtained by cloning
105 bp of the viral M gene into the pCR2.1 plasmid with a
TOPO TA cloning kit (Invitrogen, San Diego, CA, USA),
according to the manufacturer’s instructions. A linear distri-
bution (r = 0.99) was obtained between 101 and 109 copies
of standard plasmid. Data were expressed as number of cop-
ies/mL of PS; limits of detection were 10 viral copies/mL.
Statistical analysis
Patient age, number of days of hospitalization and severity
score were reported as median (range), and data were com-
pared by means of the Kruskal–Wallis test. The Fisher exact
test was used to analyse categorical independent variables.
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For continuous variables, Student’s t-test and the Mann–
Whitney U-test were used to compare parametric and non-
parametric data, respectively. Data analysis was carried out
with SPSS v. 1.3 for Windows; p-values <0.05 were consid-
ered to be significant.
Results
PCR results for respiratory viruses and quantitative real-
time PCR for A/H1N1/2009
Both PS and NW samples from 231 enrolled children were
tested for 14 respiratory viruses: a majority of acute respira-
tory infections presented with a viral pathogen (58%), with a
low percentage of double infections (4%). Overall, RSV was
the most common virus (87/135 positive samples; 64%), fol-
lowed by influenza A virus (22/135; 16%), and RV (20/135;
15%). All influenza A virus samples were identified as A/
H1N1/2009 by sequencing; no influenza B viruses were
found. hMPV was found in 5/135 positive samples (3.7%),
hBoV in 4/135 (3.0%), and coronavirus OC43 in 3/135
(2.2%); adenovirus, PIV1 and PIV3 were each detected in
only one sample (0.7%).
Determination of the number of copies of A/H1N1/2009
was retrospectively performed in the PS samples of 18 A/
H1N1/2009-positive children, with a TaqMan-based real-time
PCR technique (Table 1). In addition, PS samples taken either
at hospital discharge or at follow-up visits after a variable
number of days (median 4.5 days; range 3–27 days) were
tested for respiratory viruses; only two PS samples were
positive for A/H1N1/2009 (Table 1). No significant correla-
tion was found between number of copies of A/H1N1/2009
in the PS samples and patient data (i.e. age, length of hospi-
talization, duration of symptoms before hospitalization, clini-
cal diagnosis, oseltamivir treatment, or positivity to PCR test
performed at hospital discharge).
Respiratory virus infection rates and distribution
A/H1N1/2009 infections were found mainly in the first
weeks of November, the last few cases being found in
December (Fig. 1). During November, 19/47 (40%) enrolled
patients, representing 73% (19/26) of the viral respiratory
infections, were infected with A/H1N1/2009. Although three
RSV infections were found in November, full seasonal activity
for RSV started in December, appeared to peak in February,
and decreased in March. Throughout January and February,
RSV affected 49% (51/104) of the total number of patients
and 88% (51/58) of those who were virus-positive. RV was
found throughout the study period (Fig. 1), with two peaks,
the first being in November/December, corresponding to
the second half of the H1N1 2009 peak and the beginning of
RSV seasonal activity. After all but disappearing during Janu-
ary and February, RV peaked again in March, at the end of
the RSV season. For the two peak periods, RV infections
affected 21% (11/52) and 33% (8/24), respectively, of the
total number of patients presenting for acute respiratory
TABLE 1. Patient data and viral loads referring to pandemic A (H1N1) 2009 influenza virus (A/H1N1/2009)-positive pharyn-
geal swabs
Patient
no.
Age
(months)
Days of
hospital
stay
Duration of
symptoms before
hospitalization
(days)
Oseltamivir
treatment
(days) Diagnosis
A/H1N1
/2009
loada
Elapsed
daysb
PCR resultc
(A/H1N1/2009
loada)
3 110 0 NA No ILI 5.26 NA NA
7 18 0 NA No ILI 5.82 NA NA
11 83 23 21 Yes (5) Pneumonia 0.83 27 Negative
15 85 5 4 Yes (5) ILI 2.72 4 Negative
16 146 8 3 Yes (5) Pneumonia 3.25 7 Negative
23 1.3 5 1 No ILI 3.18 4 A/H1N1/2009 (2.96)
34 8.2 4 4 Yes (5) Wheezing 3.30 3 A/H1N1/2009 (3.05)
38 26 6 4 Yes (5) Pneumonia 4.28 5 Negative
40 34 0 NA No ILI 4.43 11 Negative
41 33 0 NA No Pneumonia 3.91 5 Negative
45 221 6 7 Yes (5) ILI 3.77 5 Negative
46 55 0 NA No ILI 4.30 NA NA
50 8.3 5 5 Yes (5) ILI 3.74 4 Negative
52 13 0 NA No Pneumonia 3.81 NA NA
53 4.1 5 3 No Wheezing 3.65 3 Negative
82 2 8 8 Yes (5) Bronchiolitis 2.77 6 Negative
121 1.1 5 1 No Bronchiolitis 3.07 4 Negative
124 10 5 8 No Pneumonia 2.51 4 Negative
ILI, influenza-like-illness, definition provided by Italian Ministry of Health, i.e. fever (temperature ‡38C), with at least one of headache, asthenia, or myalgia, and at least one
of the respiratory symptoms of cough, rhinitis, or acute pharyngitis; NA, not applicable.
aA/H1N1/2009 load: log copies/mL of pharyngeal swab (PS).
bDays elapsed between the first and the second PS, taken at enrolment and at hospital discharge or at follow-up visit.
cResult of RT-PCR tests performed on the second PS taken at hospital discharge or at follow-up visit.
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infections; 4/20 (20%) RV-infected children were co-infected
with other respiratory viruses (two RSV, one hMPV, and one
hBoV), with a significant difference in co-infection rates vs.
A/H1N1/2009 and RSV (p <0.05; chi-squared test).
Patient data and clinical diagnosis
Analysis of patient signs and symptoms at ED presentation,
and of any requirement for hospitalization or admittance to
the paediatric intensive-care unit (PICU), was performed ini-
tially between virus-negative and virus-positive patients and
then for four different virus groups (Table 2). Overall, virus-
infected patients presented with similar frequencies of fever,
cough and respiratory parameters (thoracic auscultation,
oxygen saturation (SaO2)) as virus-negative children and were
hospitalized at similar rates, but were significantly more fre-
quently admitted to the PICU (Table 2). Among the virus-
positive groups, RSV-infected children were, as expected,
significantly younger than those who tested positive for
A/H1N1/2009 and RV, presented with significantly lower sat-
uration rates, and were more frequently admitted to the
PICU than other virus groups (Table 2). Children infected
with A/H1N1/2009 presented as frequently with fever, cough
and gastrointestinal symptoms as other children with acute
respiratory infections, whether virus-positive or not, and did
not suffer from severe respiratory distress, as also docu-
mented by a significantly higher rate of negative thoracic aus-
cultation than in the other groups. The ED presentations of
RV-infected children appeared to be indistinguishable in
terms of signs and symptoms from those of other groups
(Table 2).
To better evaluate the clinical course in hospitalized
patients infected with RSV, A/H1N1/2009 and RV as single
infections, patient data were analysed with stratification by
age (Table 3). Whether in infants or in children aged
>1 year, RSV cases presented a higher severity score with
respect to A/H1N1/2009 but not to RV, whereas no signifi-
cant difference was found in number of days of hospitaliza-
tion between virus groups. For blood cell counts, several
statistically significant differences between virus groups were
found. Among children aged £1 year, those infected with RV
presented with leukocytosis (defined as white blood cell
(WBC) counts >15 000/mm3) and elevated lymphocyte and
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FIG. 1. Virus distribution in children attending an emergency depart-
ment (November 2009–March 2010). RSV, respiratory syncytial
virus; A/H1N1/2009, pandemic A (H1N1) 2009 influenza virus; RV,
rhinovirus.
TABLE 2. Patient presentation at emergency department triage
Patient data
Virus-negative
N = 96
Virus-positive
N = 135
RSV
N = 81
A/H1N1/2009
N = 22
RV
N = 16
Other viruses/co-infectionsa
N = 16
Age (months), median (range) 11 (0–132) 5 (0–593) 2 (0–51)b 26 (1–221) 13 (0–593) 6 (1–153)
Gender (male), no. (%) 49/96 (51) 70/135 (52) 44/81 (54) 12/22 (55) 7/16 (44) 7/16 (44)
Feverc, no. (%) 67/96 (70) 95/135 (70) 54/81 (67) 19/22 (86) 9/16 (56) 13/16 (81)
Cough, no. (%) 83/96 (86) 126/135 (93) 77/81 (95) 18/22 (82) 16/16 (100) 14/16 (87)
Gastrointestinal symptoms, no. (%) 40/96 (42)d 33/135 (24)d 16/81 (20) 5/22 (23) 6/16 (37) 5/16 (31)
Negative TA, no. (%) 21/96 (22) 25/135 (19) 7/81 (9) 13/22 (59)e 1/16 (6) 4/16 (25)
Crackles, no. (%) 44/96 (46) 64/135 (47) 43/81 (53) 7/22 (32) 8/16 (50) 5/16 (31)
Wheezing, no. (%) 28/96 (29) 46/135 (34) 30/81 (37) 2/22 (9) 7/16 (44) 4/16 (25)
SaO2 < 95%, no. (%) 18/96 (19) 38/135 (28) 30/81 (37)
f 2/22 (9) 2/16 (12) 4/16 (25)
Hospitalized, no. (%) 83/96 (86) 125/135 (93) 78/81 (96) 16/22 (73) 16/16 (100) 15/16 (94)
PICU, no. (%) 2/83 (2)g 22/125 (18)g 17/78 (22)h 2/16 (12)h 2/16 (12)h 1/15 (7)h
A/H1N1/2009, pandemic A (H1N1) 2009 influenza virus; PICU, paediatric intensive-care unit; RSV, respiratory syncytial virus; RV, rhinovirus; single infections only; SaO2, oxy-
gen saturation; TA, thoracic auscultation.
aThree single infection for coronavirus OC43, one single infection each for human metapneumovirus (hMPV), parainfluenza virus (PIV)3, adenovirus, and human bocavirus
(hBoV), and nine co-infections (three RSV–hMPV, two RSV–RV, one RSV–hBoV, one RV–hMPV, one RV–hBoV, and one hBoV–PIV1).
bAge in months: p <0.05 for RSV vs. A/H1N1/2009, RV, and other virus/co-infections, calculated with the Kruskal–Wallis test.
cFever (temperature ‡38.0C).
dGastrointestinal symptoms: p <0.05 for virus-negative vs. virus-positive, calculated with the chi-squared test.
eNegative TA: p <0.05 for A/H1N1/2009 vs. all other groups, calculated with the chi-squared test.
fSaO2 < 95%: p <0.05 for RSV vs. A/H1N1/2009, RV, and other virus/co-infections, calculated with the chi-squared test.
gPICU admission among hospitalized patients: p <0.05 for virus-positive vs. virus-negative, calculated with the chi-squared test.
hPICU admission among hospitalized patients: p <0.05 for RSV vs. all other groups, calculated with the chi-squared test.
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eosinophil counts as compared with those infected with RSV;
as compared with the RSV group, the A/H1N1/2009 group
presented only with significantly higher lymphocyte counts.
In children aged >1 year, the total WBC and neutrophil
counts were elevated in RV cases, at a statistically significant
level, as compared with patients infected with RSV only, but
three RV patients probably had a concomitant bacterial infec-
tion, having WBC counts >15 000/mm3 and C-reactive pro-
tein levels of approximately 9 mg/mL.
The main discharge clinical diagnoses are presented in
Table 4, distributed by respiratory virus results. Bronchiolitis
(defined as a history of upper respiratory tract infection
followed by acute onset of respiratory distress with cough,
tachypnoea, retraction and diffuse crackles on auscultation in
infants within 1 year) was the most frequent clinical
diagnosis, and 49% of these cases were RSV single infections;
the second most frequent single agent was RV (7%), whereas
16% of bronchiolitis cases were infected with other viruses
or co-infected; no viruses were found in the remaining cases.
Pneumonia was the second most frequent clinical diagnosis,
and RSV was the most frequent viral pathogen found (47% of
virus-positive cases). It is noteworthy that 7/8 children aged
>1 year affected with A/H1N1/2009 were diagnosed with
pneumonia.
RSV was also the most prevalent virus (32%) in patients
with a wheezy bronchitis diagnosis, followed by RV (15%)
and A/H1N1/2009 (7%); in 40% of wheezing patients, no
virus was detected. Children with a diagnosis of influenza-like
illness (definition provided by the Italian Ministry of Health,
i.e. fever (temperature ‡38C), with at least one of
TABLE 3. Patient clinical data, stratified by age, and distributed by respiratory virus results
Patient data: age £1 year
RSV
N = 55
A/H1N1/2009
N = 8
RV
N = 9 p-value
Hospitalization (days): median (range) 5 (3–27) 5 (3–8) 5 (4–15) NS
Severity scorea: median (range) 5 (0–8)b 1 (1–3)b 3 (0–5) <0.05b
WBC >15 000/mm3, n (%) 4/55 (7)c 1/8 (12) 4/9 (44)c <0.05c
Lymphocytes (n/mm3), median (range) 3850d (368–8418) 4447d (2368–13 007) 7901d (2772–35 552) <0.05d
Neutrophils (n/mm3), median (range) 3500 (507–20 600) 2574 (608–8536) 6105 (2298–18 564) NS
Eosinophils (n/mm3), median (range) 63e (4–638) 28e (10–405) 119e (55–1081) <0.05e
CRP >0.8 mg/mL, n (%) 16/55 (29) 3/8 (37) 5/9 (55) NS
Patient data: age >1 year
RSV
N = 23
A/H1N1/2009
N = 8
RV
N = 7 p-value
Hospitalization (days), median (range) 5 (2–18) 5 (4–23) 4 (4–9) NS
Severity scorea, median (range) 3 (0–8)b 0.5 (0–6)b 3 (1–6) 0.05b
WBC >15 000/mm3, n (%) 5/23 (22)c 2/8 (25) 5/7 (71)c <0.05c
Lymphocytes (n/mm3), median (range) 2752 (803–7595) 1058 (398–3819) 2643 (681–5632) NS
Neutrophils (n/mm3), median (range) 5932c (1062–22 480) 6186c (914–16 839) 15 935c (8480–29 352) <0.05c
Eosinophils (n/mm3), median (range) 28 (0.1–291) 26 (0.2–217) 113 (8–224) NS
CRP >0.8 mg/mL, n (%) 9/23 (39) 5/8 (62) 4/7 (57) NS
A/H1N1/2009, pandemic A (H1N1) 2009 influenza virus; CRP, blood C-reactive protein; NS, not significant; RSV, respiratory syncytial virus; RV, rhinovirus; WBC, white
blood cell; only hospitalized patients with single infections were considered.
aAge-adjusted severity score [6].
bRSV vs. A/H1N1/2009: p <0.05, calculated with Fisher’s exact test.
cRV vs. RSV: p <0.05, calculated with the Mann–Whitney U-test.
dRSV vs. A/H1N1/2009 and RSV vs. RV: p <0.05, calculated with the Mann–Whitney U-test.
eRV vs. RSV and RV vs. A/H1N1/2009: p <0.05, calculated with the Mann–Whitney U-test.
TABLE 4. Clinical diagnosis distributed by respiratory virus results
Clinical diagnosisa RSVb A/H1N1/2009b RVb Other viruses/co-infectionsb,c No virusb
Bronchiolitis:
n = 104 (3)
51 (2) (49%) 3 (0) (3%) 7 (0) (7%) 7 (1) (7%) 36 (0) (35%)
Pneumonia
n = 64 (8)
16 (0) (25%) 8 (2) (12%) 3 (0) (5%) 7 (0) (11%) 30 (6) (47%)
Wheezy bronchitis:
n = 40 (0)
13 (0) (32%) 3 (0) (7%) 6 (0) (15%) 2 (0) (5%) 16 (0) (40%)
ILId
n = 21 (12)
0 7 (4) (33%) 0 1 (5%) 13 (7) (62%)
A/H1N1/2009, pandemic A (H1N1) 2009 influenza virus; ILI, influenza-like illness; RSV, respiratory syncytial virus; RV, rhinovirus.
an, total number of cases per diagnosis; numbers in parentheses are cases not hospitalized per diagnosis.
bn, number of cases per virus group per diagnosis, numbers in parentheses are cases not hospitalized; (%) are on the total cases per diagnosis.
cThree single infection for coronavirus OC43, one single infection each for human metapneumovirus (hMPV), parainfluenza virus (PIV)3, adenovirus, and human bocavirus
(hBoV), and nine co-infections (three RSV–hMPV, two RSV–RV, one RSV–hBoV, one RV–hMPV, one RV–hBoV, and one hBoV–PIV1).
dILI definition provided by the Italian Ministry of Health, i.e. fever (temperature ‡38C), with at least one of headache, asthenia, or myalgia, and at least one of the respiratory
symptoms of cough, rhinitis, or acute pharyngitis.
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headache, asthenia, or myalgia, and at least one of the respi-
ratory symptoms of cough, rhinitis, or acute pharyngitis) had
the lowest rate of hospitalization (57%) as compared with
the other clinical diagnoses; A/H1N1/2009 infected 33% of
influenza-like illness cases, but in most of these (62%) no
respiratory virus was found.
Discussion
In the framework of a study aimed at characterizing respira-
tory virus infections, we compared signs and symptoms, lab-
oratory results and clinical outcomes in prospectively
enrolled paediatric patients seeking medical care in EDs dur-
ing the first autumn–winter season characterized by A/
H1N1/2009 circulation. The rate of A/H1N1/2009 infection
in the study period was <10%, whereas, during November,
41% (19/46) of the enrolled children were infected with A/
H1N1/2009, representing 73% (19/26) of the viral respira-
tory infections.
The national sentinel surveillance systems for influenza (In-
flunet) of the Italian Ministry of Health reported the peak in
influenza A incidence in week 45 of 2009, just when the
study period started, with 25.7 cases/1000 served population
in the 0–4-year age group and 43.1 cases/1000 in the 5–14-
year age group [9]. The reported incidence of influenza A fell
at the end of November, and in December the rates were
very low [9], according to the distribution of A/H1N1/2009
cases in our study. In addition, the national surveillance sys-
tem reported approximately 1100 laboratory-confirmed hos-
pitalized cases, 40% of which had underlying risk factors [9].
In this study, we restricted enrolment to children with no
underlying chronic diseases; Italian papers [10–12] on hospi-
talized children have reported other inclusion criteria or
focused on specific aspects, so it is difficult to compare data.
At ED presentation, no respiratory signs/symptoms could
differentiate virus infection from other causes of acute respi-
ratory syndrome, but virus-infected children were more
often admitted to the PICU than those with negative results
for respiratory viruses. Presentations of children infected
with A/H1N1/2009 were quite similar to those for other
acute respiratory infections; only RSV infections could be
associated with younger age, significantly lower oxygen satu-
ration rates, and more frequent admissions to the PICU.
Thus, as indicated in previous studies in adult patients [13–
15], ED triage assessment would not be able to separate
virus-infected patients from non-infected patients, or to iden-
tify a specific agent.
Over the study period, unlike in previous seasons, the A/
H1N1/2009 prevalence peak preceded the period in which
RSV circulated (December–March); RV circulated in Novem-
ber–December, when the A/H1N1/2009 prevalence was
declining and the RSV prevalence was rising, and in March,
when RSV circulation was diminishing. Thus, although RV
showed a tendency to circulate at the end of either the A/
H1N1/2009 or RSV peaks, RV infections also occurred at
the same time as infections with the two major respiratory
viruses, A/H1N1/2009 and RSV, and presented a rate of co-
infections (20% of positive samples) consistent with previous
reports [16,17]. Interestingly, in this study, A/H1N1/2009
occurred as a single infection, whereas RSV presented with a
low frequency of co-infection (7%). The relatively low rate of
mixed respiratory virus infections (only about 4% of the total
number of samples) and the low percentages of detection of
PIV1, PIV3 and hMPV found in this study as compared with
our previous studies [7,8], in which the same RT-PCR reac-
tions were used, could be explained by the unusual preva-
lence of an influenza A virus, A/H1N1/2009, in October–
November. In fact, several papers [18–20] have reported
changes in respiratory virus circulation in the past season,
and suggested, as a possible explanation, that the activation
of innate immunity resulting from a respiratory infection
would prevent superinfection with other respiratory patho-
gens [21]; further studies are needed to investigate this pos-
sibility.
Evaluation of the clinical characteristics of enrolled
patients confirmed that RSV is the pathogen with the highest
severity of infection in children, with the highest number of
PICU admissions, even though the total days of hospitaliza-
tion were not significantly different from those for other
groups. In our patients, leukocytosis occurred less frequently
in RSV infections than in RV and A/H1N1/2009 infections,
and lymphocyte, neutrophil and eosinophil counts were not
elevated as compared with other virus-positive groups
(Table 3) and the virus-negative group (data not shown).
These findings are consistent with previous reports, and
might imply either that leukocytes are not alerted by RSV
infection or that they are being recruited at specific sites
away from the circulating blood, as has been suggested by
others [22–24]. Lymphocyte and eosinophil counts were sig-
nificantly increased in RV-infected infants as compared with
other groups; as blood eosinophil counts are predictors of
reactive airway disease, our finding is consistent with studies
reporting early RV infections as an important risk factor for
recurrent wheezing [25,26].
Patients infected with A/H1N1/2009 experienced a mild
clinical course overall, as documented by severity scores that
were significantly lower than those for RSV cases; neverthe-
less, in our series, 7/8 (87%) A/H1N1/2009-infected children
aged >1 year had a final clinical diagnosis of pneumonia. The
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rate of A/H1N1/2009 pneumonia diagnosis found in this
study is consistent with previous reports of A/H1N1/2009
pulmonary replication greater than that expected from a sea-
sonal influenza virus [5,27]. It has been suggested that the
greater rate of pneumonia might perhaps differentiate A/
H1N1/2009 from seasonal influenza [4]; however, this crite-
rion will not help to discriminate it from other respiratory
virus infections, as pneumonia, being a clinical diagnosis, is
not suggestive of a specific viral infection.
If diagnostic tests are not performed, epidemiological and
clinical criteria could lead to the misdiagnosis of viral infec-
tions for which specific treatments might be available. Even
though specific antiviral drugs are currently used only in
cases of influenza virus infection, the usefulness of proper
treatment against RSV and RV infections in infants would be
improved by the use of virological molecular diagnosis. As an
example, even though treatment with systemic corticoster-
oids is not recommended in cases of RSV infection, it has
been reported that administration of prednisolone to hospi-
talized children with first episodes of wheezing associated
with RV infection reduces the frequency of relapse [28].
In conclusion, in the season characterized by the first
autumn–winter circulation of a new pandemic influenza virus,
RSV was the most frequent and relevant respiratory virus
determining ED consultations for children of any age, A/
H1N1/2009 was confirmed as a mild pathogen but with a
relevant rate of pulmonary replication, and RV was estab-
lished as the third most relevant agent for children’s hospi-
talization for respiratory infections. Considering the fact that
clinical presentation is not useful in discriminating between
viral pathogens, a timely virological diagnosis is essential in
order to separate infected patients during pandemic alerts or
at-risk children, and in order to prescribe specific treatments
for influenza A virus, RSV and RV infections.
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